tiprankstipranks
Fusen Pharmaceutical Co., Ltd. (HK:1652)
:1652
Hong Kong Market
1652
Fusen Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports
Want to see HK:1652 full AI Analyst Report?

Fusen Pharmaceutical Co., Ltd. (1652) Financial Statements

0 Followers

Fusen Pharmaceutical Co., Ltd. Financial Overview

Fusen Pharmaceutical Co., Ltd.'s market cap is currently HK$823.45M. The company's EPS TTM is HK$-0.0161; its P/E ratio is -45.08; Fusen Pharmaceutical Co., Ltd. is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 273.37M¥ 326.03M¥ 565.61M¥ 491.76M¥ 385.66M
Gross Profit¥ 109.79M¥ 162.64M¥ 299.51M¥ 225.02M¥ 211.13M
Operating Income¥ -1.72M¥ -67.51M¥ 20.02M¥ 15.74M¥ 52.14M
EBITDA¥ 25.55M¥ -39.07M¥ 18.93M¥ 49.90M¥ 55.82M
Net Income¥ -11.78M¥ -188.78M¥ -36.28M¥ -34.65M¥ 16.64M
Balance Sheet
Cash & Short-Term Investments¥ 83.88M¥ 21.06M¥ 34.85M¥ 128.11M¥ 81.70M
Total Assets¥ 1.26B¥ 1.24B¥ 1.34B¥ 1.35B¥ 1.24B
Total Debt¥ 324.34M¥ 383.69M¥ 344.12M¥ 228.38M¥ 240.69M
Net Debt¥ 240.46M¥ 362.64M¥ 309.27M¥ 100.28M¥ 159.63M
Total Liabilities¥ 891.02M¥ 869.80M¥ 781.52M¥ 737.38M¥ 582.39M
Stockholders' Equity¥ 359.40M¥ 369.67M¥ 563.52M¥ 614.17M¥ 658.17M
Cash Flow
Free Cash Flow¥ 69.98M¥ 57.43M¥ -161.84M¥ 86.63M¥ -62.37M
Operating Cash Flow¥ 121.93M¥ 133.73M¥ -73.33M¥ 110.49M¥ 47.77M
Investing Cash Flow¥ -5.88M¥ -163.42M¥ -108.32M¥ -13.13M¥ -282.98M
Financing Cash Flow¥ -56.21M¥ 15.99M¥ 88.50M¥ -51.77M¥ 20.53M
Currency in CNY

Fusen Pharmaceutical Co., Ltd. Earnings and Revenue History

Income Statement >

Fusen Pharmaceutical Co., Ltd. Debt to Assets

Balance Sheet >

Fusen Pharmaceutical Co., Ltd. Cash Flow

Cash Flow >

Fusen Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

Earnings >